Unpaired deep learning for pharmacokinetic parameter estimation from dynamic contrast-enhanced MRI without AIF measurements

被引:2
|
作者
Oh, Gyutaek [1 ]
Moon, Yeonsil [2 ]
Moon, Won-Jin [3 ]
Ye, Jong Chul [4 ]
机构
[1] Korea Adv Inst Sci & Technol KAIST, Dept Bio & Brain Engn, 291 Daehak Ro, Daejeon 34141, South Korea
[2] Konkuk Univ, Med Ctr, Dept Neurol, 120-1 Neungdong Ro, Seoul 05030, South Korea
[3] Konkuk Univ, Dept Radiol, Med Ctr, 120 1 Neungdong Ro, Seoul 05030, South Korea
[4] Korea Adv Inst Sci & Technol KAIST, Kim Jaechul Grad Sch AI, 291 Daehak Ro, Daejeon 34141, South Korea
基金
新加坡国家研究基金会;
关键词
Dynamic contrast-enhanced MRI; Unpaired deep learning; Optimal transport; CycleGAN; DCE-MRI; KINETIC-PARAMETERS; SELECTION; CYCLEGAN; TRACER;
D O I
10.1016/j.neuroimage.2024.120571
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
DCE-MRI provides information about vascular permeability and tissue perfusion through the acquisition of pharmacokinetic parameters. However, traditional methods for estimating these pharmacokinetic parameters involve fitting tracer kinetic models, which often suffer from computational complexity and low accuracy due to noisy arterial input function (AIF) measurements. Although some deep learning approaches have been proposed to tackle these challenges, most existing methods rely on supervised learning that requires paired input DCE-MRI and labeled pharmacokinetic parameter maps. This dependency on labeled data introduces significant time and resource constraints and potential noise in the labels, making supervised learning methods often impractical. To address these limitations, we present a novel unpaired deep learning method for estimating pharmacokinetic parameters and the AIF using a physics -driven CycleGAN approach. Our proposed CycleGAN framework is designed based on the underlying physics model, resulting in a simpler architecture with a single generator and discriminator pair. Crucially, our experimental results indicate that our method does not necessitate separate AIF measurements and produces more reliable pharmacokinetic parameters than other techniques.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Differentiation of infective from neoplastic brain lesions by dynamic contrast-enhanced MRI
    Haris, Mohammad
    Gupta, Rakesh Kumar
    Singh, Anup
    Husain, Nuzhat
    Husain, Mazhar
    Pandey, Chandra Mohan
    Srivastava, Chhitij
    Behari, Sanjay
    Rathore, Ram Kishore Singh
    NEURORADIOLOGY, 2008, 50 (06) : 531 - 540
  • [42] Repeatability of tumor perfusion kinetics from dynamic contrast-enhanced MRI in glioblastoma
    Woodall, Ryan T.
    Sahoo, Prativa
    Cui, Yujie
    Chen, Bihong T.
    Shiroishi, Mark S.
    Lavini, Cristina
    Frankel, Paul
    Gutova, Margarita
    Brown, Christine E.
    Munson, Jennifer M.
    Rockne, Russell C.
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [43] Quantitative pharmacokinetic parameter Ktrans map assists in regional segmentation of nasopharyngeal carcinoma in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)
    Huang, Junhui
    Yang, Shangpo
    Zou, Liyan
    Chen, Yingying
    Yang, Long
    Yao, Bingyu
    Huang, Zhenxing
    Zhong, Yihong
    Liu, Zhou
    Zhang, Na
    BIOMEDICAL SIGNAL PROCESSING AND CONTROL, 2024, 87
  • [44] Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters
    Danjun Song
    Yueyue Wang
    Wentao Wang
    Yining Wang
    Jiabin Cai
    Kai Zhu
    Minzhi Lv
    Qiang Gao
    Jian Zhou
    Jia Fan
    Shengxiang Rao
    Manning Wang
    Xiaoying Wang
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 3757 - 3767
  • [45] Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters
    Song, Danjun
    Wang, Yueyue
    Wang, Wentao
    Wang, Yining
    Cai, Jiabin
    Zhu, Kai
    Lv, Minzhi
    Gao, Qiang
    Zhou, Jian
    Fan, Jia
    Rao, Shengxiang
    Wang, Manning
    Wang, Xiaoying
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (12) : 3757 - 3767
  • [46] T2*-correction in dynamic contrast-enhanced MRI from double-echo acquisitions
    Kleppesto, Magne
    Larsson, Christopher
    Groote, Inge
    Salo, Raimo
    Vardal, Jonas
    Courivaud, Frederic
    Bjornerud, Alte
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2014, 39 (05) : 1314 - 1319
  • [47] Dynamic Contrast-Enhanced MRI in Mice at High Field: Estimation of the Arterial Input Function Can be Achieved by Phase Imaging
    Fruytier, A. -C.
    Magat, J.
    Colliez, F.
    Jordan, B.
    Cron, G.
    Gallez, B.
    MAGNETIC RESONANCE IN MEDICINE, 2014, 71 (02) : 544 - 550
  • [48] Pharmacokinetic Changes Induced by Focused Ultrasound in Glioma-Bearing Rats as Measured by Dynamic Contrast-Enhanced MRI
    Yang, Feng-Yi
    Ko, Chia-En
    Huang, Sheng-Yao
    Chung, I-Fang
    Chen, Gin-Shin
    PLOS ONE, 2014, 9 (03):
  • [49] Deep Learning Radiomics Model of Dynamic Contrast-Enhanced MRI for Evaluating Vessels Encapsulating Tumor Clusters and Prognosis in Hepatocellular Carcinoma
    Dong, Xue
    Yang, Jiawen
    Zhang, Binhao
    Li, Yujing
    Wang, Guanliang
    Chen, Jinyao
    Wei, Yuguo
    Zhang, Huangqi
    Chen, Qingqing
    Jin, Shengze
    Wang, Lingxia
    He, Haiqing
    Gan, Meifu
    Ji, Wenbin
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2023, : 108 - 119
  • [50] R2* Relaxation Affects Pharmacokinetic Analysis of Dynamic Contrast-Enhanced MRI in Cancer and Underestimates Treatment Response at 7 T
    Kim, Jana
    Moestue, Siver A.
    Bathen, Tone F.
    Kim, Eugene
    TOMOGRAPHY, 2019, 5 (03) : 308 - 319